Imidazoles play an important role in medicinal chemistry, because many of its derivatives have demonstrated significant biological activity. This article is a revision of the last years, of the synthesis methods used in the preparation of imidazole derivatives which have shown biological activity as antibacterial, antiinflammatory, analgesic, antifungal, anticancer, antidepressants, including inside the biological activities of different therapeutic diseases.
Introduction
The imidazole (1,3-diaza-2,4-cyclopentadiene) is a planar, five membered heteroaromatic molecule with 3C and 2N atom in 1 and 3 positions. It was first named as gluoxaline (first synthesis with glyoxal and ammonia). Amphoteric nature is susceptible to electrophilic and nucleophilic attack. Highly stable to thermal, acid, base, oxidation and reduction conditions. It has extensive intramolecular hydrogen bonding. It exists in two equivalent tautomeric forms because the hydrogen atom can be located on either of the two nitrogen atoms. The compound is classified as aromatic due to the presence of a sextet of π-electrons, consisting of a pair of electrons from the protonated nitrogen atom and one from each of the remaining four atoms of the ring.
Imidiazole is amphoteric, because it functions as an acid as well as a base. As an acid, the pKa of imidazole is 14.5, making it less acidic than carboxylic acids, phenols and imides, but slightly more acidic than alcohols. The acidic proton is located on N-1. As a base, the pKa of the conjugated acid (cited below as pKBH+ to avoid confusion between the two) is approximately 7, making imidazole approximately sixty times more basic than pyridine. These properties are explained by the resonance interactions, which increase the basicity of the 3-nitrogen atom. Some resonance structures of imidazole are shown in scheme 1. Imidazole was first reported for Debus et al., in 1858 from diketone an aldehyde and ammonia although various imidazole derivatives had been discovered earlier in the 1840s. Since then, this particular heterocyclic family has hugely expanded and imidazoles are found today in a myriad of applications. They play an important role in areas such as natural products (Brown et al., 1998; Forte et al., 2009 ), medicinal chemistry (Brown et al., 1998) , material sciences for nonlinear optical application (Wang et al., 2002) , some imidazole derivatives are used as a catalyst in industrial uses (Louie et al., 2002; Doung et al., 2004 ) also they have been used as corrosion inhibitors for iron in acidic medium (Abdallah et al., 2012) , on certain transition metals, such as copper (Antonijevic et al., 2008) and carbon steel (Bereket et al., 2002) . Imidazole can also be found in various compounds which are used for photography (Nakamura et al., 1998; Clark et al., 2005) and these derivatives are used as dopants for doping an organic semiconductor matrix material, organic semiconductor materials and electronic or optoelectronic structural elements (Hartmann et al., 2010) .
In the last year's reviews of different aspects of compounds, which contain imidazole, have been performed, the most recent is the convenient approach for the synthesis of imidazole derivatives using microwaves for Chawla et al.,(2012) . Hernández et al.
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The relevant advances in the design of new multichannel imidazole-based receptors capable of recognizing different types of analytes were reported by Molina et al.,(2012) . On the other hand the chemistry of imidazole and its pharmacological actions was reported too (Kumar, 2010; Shalini et al., 2010; Bhatnagar et al., 2011) . A review focusing only on alkaloids possessing a clear pharmacological value with the total synthesis of the pyrrol imidazole alkaloids (PIAs) originated from marine sponges was reported by Forte et al., (2009) . The report from Bellina et al., (2007) described the synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles.
This review highlights mainly the synthesis of compounds containing imidazole and his pharmaceutical importance. The derivatives of imidazole have intensive synthetic interest due to their important biological activities, and many of these compounds are candidates for drug development and have therefore drawn the attention of various research groups.
Imidazole with Antibacterial and Antiinflammatory Activity
In the synthesis of substituted imidazole derivatives reported for Sharma D. et al.,(2009) , the intermediates, 2-(substituted phenyl)-1H-imidazoles (1-12) were the key for the obtention of compounds 13-26. The compounds (1-12) were prepared by the condensation of imidazoles with the corresponding substituted aryldiazonium chlorides, which were prepared by the diazotization of substituted anilines. The coupling with the imidazole was carried out using sodium acetate. The intermediates (1-12) were reacted with substituted benzoyl chloride that was prepared by the reaction of substituted benzoic acid with thionyl chloride (scheme 2, table 1). The compounds 14, 16, 21 and 26 have antifungal activity significantly active against A. niger, and the compounds 22, 25 and 26 shown activity against C. albicans in both casesusing fluconazole as control. Finally the compounds 16 and 19 could be selected as lead compounds for the development of novel antiviral agents because of present antiviral activity equivalent to that of the standard drugs brivudin and cidofovir.
A series of imidazole based compounds were synthesized by Pandeyet al., (2009) .The synthesis of compounds 29-31 starting by reaction of imidazole (27) with 3,4-dichlorobenzyl bromide, ethyl bromoacetate and ethyl bromopropionate separately in THF in the presence of NaH/TBAB gave 1-(3,4-dichlorobenzyl)-1H-imidazole (29), imidazol-1-yl-acetic acid ethyl ester (30) and 3-imidazol-1-yl-propionic acid ethyl ester (31) respectively in quantitative yield (scheme 3).
Scheme 3 . Synthesis of N-alkyl(aralkyl)imidazoles. Reactions conditions: (a) R1-X, THF, NaH/TBAB (yield 65-70%) were prepared by amidation of compound 30 with different amines. n-butyl, n-hexyl, n-heptylamine, and benzylamine under refluxing condition DBU to giverespective carboxamides. LiAlH 4 reduction of the above compound 30 gave respective 1-(2-hydroxy ethyl)-1H-imidazole36 in good yield. The latter, on mesylation with methanesulphonyl chloride followed by reaction with benzyl amine in presence of DBU gave 1-(2-benzyl aminoethyl)-1H-imidazole 37 in quantitative yield (scheme 4). On the other side the compounds 39 and 40 were prepared by benzylation of benzimidazole 38 with benzyl bromide and 3,4-dichlorobenzyl bromide respectively (scheme 5). Compounds 41-44 were prepared by the reaction of imidazole (27 or 28) with dibromoalkanes in presence of NaH and TBAB in THF (scheme 6). The reaction of 2 eq. of imidazole with 1 eq. of 1,3-dibromopropane and 1,5-dibromopentane separately led to the formation of compounds 41 and 42 respectively in good yields. However, reacting 2 eq. of 2-propylimidazole with 1 eq. of 1,3-dibromopropane gave the expected 1,3-bis-(2-propylimidazol-1-yl)-propane (43) as major product along with another unusual minor product, 1-(4-allyl-2-propylimidazol-1-yl)-3-(2-propylimidazol-1-yl)-propane (44) . The synthesized compounds were screened against Mycobacterium tuberculosis, using Ethambutol (EMB) and isoniazid (INH) as control; the compound 43 exhibited very good in vitro antitubercular activity and may serve as a lead for further optimization. Husain et al., (2009) described the synthesis of disubstituted imidazoles (46a-i). These products were prepared by reacting appropriate phenylglyoxal (45a,b) with different aryl aldehydes in the presence of ammonium acetate. The required phenylglyoxals (starting material) were prepared by refluxing viastirring acetophenone/4-chloroacetophenone in dioxane with selenium dioxide. Trisubstituted imidazoles (47a-i) were prepared by reacting disubstituted imidazole (46a-i) with chlorobenzene in the presence of catalytic amount of triethylamine (TEA) (scheme 7). The results indicated that compounds 47c and 47g showed significant antiinflammatory activity with very low ulcerogenicity. Some compounds like 46f, 46i, 47d, 47f, 47h, and 47i also showed significant antimicrobial activity. Puratchikody and Doble, (2007) described the synthesis and pharmacological evaluation pertaining to antinociceptive (hot plate and tail flick) and antiinflammatory (based on Carrageenan-induced paw oedema) activities, and QSAR studies on 2-substituted-4,5-diphenyl-1H-imidazoles. The synthesis was performed by condensation of benzil with ammonium acetate and appropriate aldehydes in presence of glacial acetic acid. Substituted benzaldehyde(s) is used to obtain compounds 48-68. Aldehyde containing alkyl, alkenyl or styryl unit were used to give compounds 69-72 (scheme 8, table 2). For antinociceptive and antiinflamatory activities was used pentazocine and indomethacine as standard respectively, in both the Tween suspension was as control. Compounds with phenyl substitution with -F, -Cl, -NH 2 , -N(CH 3 ) 2 , -OH and -OCH 3 at p-position (compounds 59, 60, 64, 65, 66 and 68, respectively) showed higher activity than all other substitutions in both studies. Electron-donating groups and hydrophilicity play an important role in the biological activity, lowering of activity was observed with hydrophobic groups.
New bis-imidazole derivatives have been synthesized for Zampieriet al., (2007) with this synthesis the corresponding substituted arylmethylketones and thienylmethylketones with paraformaldehyde and dimethylamine hydrochloride in acetic acid were prepared the [(dimethylamino) methyl]-propenones 74a-h and 2-[(dimethylamino)methyl]-1-(thiophene-2-yl)-propenones 74i-k as hydrochlorides. 
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The nucleophilic attack of imidazole both on carbon bearing the dimethylamino group and ,-unsaturated ketone moiety via a Michael type reaction, allowed the formation of 1-aryl-3-(1H-imidazol-1-yl)-2-[(1H-imidazol-1-yl) methyl]-propan-1-one derivatives 73a-h and 3-(1H-imidazol-1-yl)-2-[(1H-imidazol-1-yl)methyl]-1-(thiophen-2-yl)-propan-1-one derivatives 73i-k, by microwave (MW) irradiation of the reagent mixture in EtOH-H 2 O at room temperature. The reduction of the above obtained ketone derivatives73a-h with NaBH 4 produced the secondary alcohols 73l-m (scheme 9). All the bis-imidazole derivatives exhibited some degree of antifungal and antimycobacterial activity; compound 73h in which the biphenylyl moiety is present is the most active antifungal derivative in the series. The activity was higher than that of the reference drug miconazole and similar to the activity of amphotericin B. On the other hand the compound 73a-m was also tested for antitubercular activity against the reference strain of M. tuberculosis H37RV, in comparison with rifampicin. But in this case only exhibited moderate activity, with MIC values in the range of 8-64 mg/mL.
Imidazole with Antifungal Activity
N-Substituted Derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole were reported by Di Santo et al., (2005) .The synthesis started with the alkylation of pyrroles 87a-g (scheme 10, table 3) with the appropriate alkyl halide in alkaline medium (K 2 CO 3 ) to give N-alkylpyrrolylmethanones 88a-c,e,h-t. For the compound 88f it necessary to use NaH as a catalyst by reaction of dimethylallyl bromide with 87a. The compound 88g was obtained by Suzuki reaction conditions using phenylboronic acid, Cu(II) acetate, pyridine and Nmethylpyrrolidone by microwave-assisted. The imidazoles 75c-e,g,h,j,76b,c, 77d-f,78b,79b-e,80b,c and 81b (table 3) were afford by reduction of ketones 88a-c, e-t with LiAlH 4 to give compounds 89a-c, e-t which werethen treated with 1,1'-carbonyldiimidazole (CDI).
The derivatives 82a-c (scheme 11, table 3) were synthesized by a similar synthetic pathway. The compound 87h was obtained by the condensation of the naphthalene-1-carboxaldehyde with 2',4'-dichloroacetophenone in aqueous sodium hydroxide to afford propenone 90, followed by TosMIC cycloaddition in the presence of sodium hydride. On the other hand the reaction of 87a with 1,2-dichloroethane (tetrabutylammonium hydrogen sulfate (Bu 4 NHSO 4 ), aqueous sodium hydroxide and dichloromethane) gave the expected methanone 88d, reduction of 88d furnished the corresponding alcohol 89d, which was condensed with CDI to afford imidazole derivative 75f (scheme 12). Finallydirect reaction of 75a with methyl propiolate in the presence of tetrabutylammonium fluoride (Bu 4 NF) (scheme 13), gave derivative 75i. 
Derivatives 75c-j, 76b,c, 77d-f, 78b, 79b-e, 80b,c, 81b and82a-c showed high potency against Candida albicans, and the most active derivative was compound 75d, which was more potent than the reference.
Imidazole with Antiparasiticactivity
The effect of cis-2-(1H-imidazole-2-yl)-1H-imidazole dichloro platinum (II) on the in-vitro formation of β-Hematin was reported by Akkawiet al., (2012).
The compound cis-2-(1H-imidazol-2-yl)-1H-imidazole
Dichloro Platinum (ll) 94complex was prepared by mixing two solutions of 1N HCl, the first one containing potassium tetrachloroplatinate (K 2 PtCl 4 ) and the second containing 2,2'-Biimidazole 92. On the other hand the compound cis-1-methyl-2-(1-methyl-1H-imidazole-2-yl)-1H-imidazole dichloro platinum (II) 95 was prepared in a similar way as the above compound but using 1,1'-dimethyl-2,2'-Biimidazole 93(scheme 14). Cisplatin complexes not only have anti-tumor activity, as proposed by others, but also they have the ability to inhibit the formation of β-hematin in in-vitro systems. The study revealed that cis-2-(1H-imidazol-2-yl)-1H-imidazole dichloro platinum (ll) was more effective against β-hematin formation than Cis-1-methyl-2-(1-methyl-1H-imidazole-2-yl)-1H-imidazole dichloro Platinum (ll).
Lakshmananet al., (2011)reported the synthesisof1-substituted imidazole derivatives, the N-phenacyl 2-methyl imidazole derivatives96a-d were obtained for treatment of 2-methyl imidazole with the appropriate para substituted phenacyl bromides in presence of dry DMF in cold stirring (5-10°C) for 3-6 h. On the other hand the N-phenacyl imidazole derivatives 97a-d were synthetized for treatment of imidazole and of appropriate para substituted phenacyl bromides in the same conditions that 96a-d (scheme 15). The synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles were reported by Bhandari et al., (2010) .Ketone (acetone, acetophenone or propiophenone) 98a-98c was reacted with pyrrolidine and paraformaldehydeunder asymmetric Mannich conditions in the presence of L-proline to give the corresponding Mannichproducts. Subsequent replacement of the pyrrolidine with imidazole (amine exchange reaction to give 99a and 99b, 99c) followed by sodium borohydridereduction gave the hydroxyl intermediates 100a-100c. Condensation of the hydroxyl intermediates 100a, 100b and cis 100c isomer (major product) with substituted aryl halides furnished the required ethers 101-111 (105and106 were obtained as cis diastereomers) scheme 16. For the formation of final compounds aryloxy aryl alkyl imidazoles (115-118) and diaryloxy alkyl imidazoles (119-122), following it was used the regioselective ring opening of styrene epoxide (112) or phenoxy methyl oxirane (113)with imidazole gave the corresponding alcohols 114a and 114b, SN Ar substitution with an aryl fluoride generated the targeted aryloxy ethers 115-122scheme 17. All the 19 compounds exhibited 94-100% inhibition at 10 µg/mL against promastigotes and 12 compounds exhibited high inhibition with an IC 50 in the range of 0.47-4.85 g/mL against amastigotes. Promising compounds were tested further in vivo. Among all, compounds 101 and 120 with 4-CF 3 aryloxy moiety exhibited medium in vivo inhibition of 58-60%, thus providing new structural lead for antileishmanials.
The synthesis of analogs of tipifarnib (123, table 4) as inhibitors of Tc-L14DM and as anti-T.cruzi agents was reported for Kraus et al., (2010) . The synthesis started with the formation of Weinreb amide 125from 5-bromoisatoic anhydride in presence of pyridine, this amide reacts with a variety of phenyl lithiums to give ketone 126. Acetylation of the amino group followed by intramolecular ring closure using tBuOK gives quinolone 127. Conversion of 127 to the set of compounds 132was carried out as described in earlier study (Kraus et al., 2009) The synthesis of tipifarnib analogs is depicted in scheme 20. Commercially available halogenated cinnamic acid 133 was converted to the acid chloride and thenreacted with 4-bromoaniline to give amide 134. IntramolecularFriedel-Crafts alkylation proceeded smoothly with concentratedH 2 SO 4 to give lactam 352. Conversion to the quinolonewas accomplished by oxidation of 135 with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone to give 136. The latter was convertedto the desired tipifarnib analogues by using steps fromscheme 18. The compound 132, which lacks an ortho substituent (so no rotamers are possible) and also lacks the 3-chloro group, which is important for binding to protein farnesyltransferase. This compound ranks among the most potent of the compounds against T. cruzi and displays an intermediate loss in affinity for protein farnesyltransferase. The posaconazole was used as standard. The synthesis of 2-substituted-4,5-diphenyl imidazoles 163a-j was reported by Dutta et al., (2010) the compounds were synthetized by refluxing benzyl with different substituted aldehydes in the presence of ammonium acetate and glacial acetic acid (scheme 21).
Scheme 21. (a) Refluxing, CH 3 CO 2 H, (yield 32-80%)
The compound 163b, 163c, 3163e, 163g, 163h were found to have improved anthelmintic activity compared to albendazole and piperazine citrate.
Imidazole with Antiviral Activity
The synthesis of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin 2-yl) imidazole-1-D-ribofuranoside was reported by Ujjinamatadaet al., (2007) . The synthesis started with ethyl 5-diethoxymethylimidazole-4-carboxylate 164 by reaction with NaH to convert in sodium salt and was further reacted with 2,3,5-tri-O-benzoyl-β-D-ribofuranosyl-1-iodide under standard conditions of glycosylation to give ethyl 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-(diethoxymethyl)imidazole-4-carboxylate165. The acetal 165 was reacted with 80% aqueous acetic acid to obtain the corresponding carboxaldehyde 166. The reaction of the latter with excess guanidine in ethanol at reflux provided the target nucleoside 167(scheme 22). Compound167 was evaluated in vitro against NTPases/helicases of four different viruses of the Flaviviridae family, including the West Nile virus (WNV), hepatititis C virus (HCV), dengue virus (DENV), and the Japanese encephalitis virus (JEV), employing both RNA and a DNA substrate. The compound showed activity against NTPase/helicase of WNV and HCV with an IC 50 of 23 and 37 M, respectively, when a DNA substrate was employed; while no activity was observed when an RNA substrate was used.
Imidazole with Anticancer activity
Özkayet al., (2010) reported the synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl) phenyl]acetamide derivatives. Anticancer agent cisplatin was used as a positive control. The 175, 179, 180 and 181are the most cytotoxic compounds in the series. Specially the compounds 179, 180and181indicated significant anticancer activity against colon carcinoma cell line. These three compounds showed substantial cytotoxicity and caused DNA fragmentation of the HT-29 cells. Finlay et al., (2008) reported obtaining of imidazole piperazines, the synthesis began with the coupling of4-fluoro-nitrobenzene193 with 1-acetylpiperazine 194 under basic conditions. Following reduction of the nitro group, the resulting aniline 195 was reacted with cyanamide to produce guanidine 196 as the bicarbonate salt. Cyclisation with the known aminopropenone 197followed by hydrolysis gave the piperazine 198 (scheme 24). Further reaction with 2-chloro-1-ethanesulfonyl chloride followed by in situ elimination gave the vinyl sulfonamide.
This could undergo conjugate addition with both sodium methoxide and dimethylamine to give 192c and 192d, respectively. The compounds 192e and 192f were obtained by coupling with activated carboxylic acids (e.g., glycolic acid or S-lactic acid) leading to amides 192eand 192f.Basic amides (192g and192h) were accessed by reaction with chloro-acetyl chloride followed by displacement with dimethylamine or diethylamine(scheme 25, table 5). 
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Piperazines 192e and 192i were subsequently shown to inhibit tumour growth when dosed orally in a nude mouse xenograft study. Jones et al., (2008) described the synthesis of novel series of imidazole pyrimidine amides, the route developed to obtain these compounds is shown in scheme 28. Palladium catalysed coupling with ethyl 4-iodobenzoate followed by hydrolysis gave the corresponding acids 206. These acid intermediates were subject to late stage diversification by coupling with amines to give the amides (207a-214a and207b-214b).
Alternatively, for larger scale work it proved more convenient to couple the 4-iodoarylamides directly with the aminopyrimidines 205 using palladium catalysis (scheme 28). The 4-iodoarylamides were readily obtained by reaction of the required amine with 4-iodobenzoyl chloride. Similar routes using 4-bromo-2-fluoroarylamides were used to obtain the ortho-fluoro substituted amides (208c,d and209c,d, table 6) . The 4-bromo-2-fluoroarylamides were obtained by reacting the corresponding acid under standard amide coupling conditions (HATU, NEt 3 , DMF) with the requisite amine. For the compounds 215-217 the commercially available (R)-3-hydroxypyrrolidine was used and it was coupled with 4-iodobenzoyl chloride 212 then activated as the methanesulfonyl ester 213. Displacementwith inversion of stereochemistry occurred smoothly with a range of primary and secondary amines to give the (S)-4-iodoarylamide coupling partners 214. Subsequent coupling with the appropriate aminopyrimidine under Buchwald-Hartwig conditions, gave the chiral, non-racemic pyrrolidine products in good yield (scheme 29). The imidazole pyrimidine amides possess excellent levels of anti-proliferative potency against cancer cell lines. A lead compound, (S)-q2 217b (AZD5597), was selected from the series for further development as a CDK inhibitor suitable for intravenous dosing. 
Imidazole with Antidepressant Activity
Hadizadeh et al.,(2008) reported the synthesis of N-Substituted Imidazole-5-Carboxamides.
Benzylamine hydrochloride 218 was stirred with 1, 3-dihydroxyacetone dimmer and potassium thiocyanate to give 5-hydroxymethyl-2-mercapto-1-benzylimidazole 219. Subsequent alkylation of compound 219 with alkyl halides resulted in 2-alkylthio-1-benzyl-5-hydroxymethylimidazole 220. Oxidation of 220 with manganese dioxide gave 221, which was further oxidized by being boiled in alkaline solution of silver nitrate to give 2-alkylthio-1-benzylimidazole-5-carboxylic acid 222. Compound 222was converted to its acid halide 223. 2-Morpholinoethylamie was added dropwise to a solution of 223 in dry THF (tetrahydrofuran) to give N- [2-(4-morpholinyl) ethyl)]-1-benzyl-2-(alkylthio)-1H-imidazole-5-carboxamides 224a-c (scheme 30). 
Conclusion
Developed approaches have been amplified for the synthesis of different imidazole derivatives with important biological activities as antibacterial, antiinflammatory, analgesic, antifulgal, antiparasitic, antiviral, anticancer, antidepressant, etc. The modifications in the substituents at 1, 2, 4 and 5 position of the basic imidazole nucleus results in the potent biological activities. The challengefor prospective research in this area of syntheticorganic chemistry involves the optimization of known procedureson the one hand, and the development of newuseful synthetic approaches on the other.
